Lemierre's syndrome (also known as post-anginal septicemia or necrobacillosis) is a rare but life-threatening condition characterized by the classic triad of oropharyngeal infection, septic thrombophlebitis of the internal jugular vein (IJV), and metastatic septic emboli — most commonly to the lungs. [1-2] It is most often caused by Fusobacterium necrophorum, a Gram-negative anaerobic rod. [1-3] Often called the "forgotten disease," its incidence has been rising over the past decade, potentially linked to decreased antibiotic prescribing for upper respiratory infections. [2][4]
1. History
- Recent pharyngitis/tonsillitis is the antecedent infection in >85% of cases. Ask about sore throat onset, duration, and whether symptoms initially improved then worsened ("double-sickening" pattern). [1-2]
- Timing: Typically 4–12 days from initial pharyngitis to development of septic complications. Patients with >14 days of symptoms before treatment are at higher risk for distant manifestations. [5]
- Neck pain/swelling: Unilateral, often along the sternocleidomastoid (SCM) — a critical clue. [1][3]
- Fever with rigors — often high-grade, persistent despite initial antibiotics. [6]
- Respiratory symptoms: Cough, pleuritic chest pain, dyspnea, hemoptysis suggest pulmonary septic emboli. [7-8]
- Joint pain/swelling: Septic arthritis is a recognized metastatic complication. [3]
- Ask about recent dental procedures, peritonsillar abscess, otitis, mastoiditis, or head/neck trauma as atypical antecedent events. [9-10]
2. Alarm Features
- Pharyngitis that worsens after initial improvement or fails to resolve after 5–7 days [1]
- Unilateral neck pain/swelling/tenderness along the SCM in a febrile patient with recent pharyngitis [1][3]
- Sepsis/septic shock: Hypotension, tachycardia, altered mental status — 83% of Lemierre's patients meet sepsis criteria on admission; 18% develop septic shock [11]
- Respiratory distress suggesting septic pulmonary emboli [8]
- New neurologic deficits — brain abscess is a rare but devastating complication [3]
- Critically ill young patient with a preceding sore throat — this combination should always trigger consideration of Lemierre's [1]
3. Medications
- Empiric antibiotics: Broad-spectrum IV coverage targeting anaerobes and oropharyngeal flora:
- β-lactam/β-lactamase inhibitor (e.g., piperacillin-tazobactam or ampicillin-sulbactam) PLUS metronidazole [2-3]
- Alternative: Carbapenem (meropenem or imipenem) for severe/refractory cases
- MRSA coverage (vancomycin) should be considered empirically in at-risk patients (IVDU, undomiciled, recent hospitalization, recent antibiotics) until cultures return [10]
- Duration: 3–6 weeks of antimicrobial therapy; typically IV initially, then transition to oral [2]
- Anticoagulation: Controversial. The largest study to date (n=156) found no statistically significant survival benefit with anticoagulation. Consider on a case-by-case basis, particularly with thrombus extension, persistent bacteremia, or central venous thrombosis. If used, duration is typically 6–12 weeks. DOACs appear to have similar outcomes to warfarin. [10][12-13]
- Avoid: Macrolides alone are insufficient (poor anaerobic coverage). Fusobacterium species are generally resistant to erythromycin and may have variable susceptibility to clindamycin. [2]
4. Diet
- Hydration is critical during the acute septic phase — aggressive IV fluid resuscitation as part of sepsis management.
- Patients with severe pharyngitis/dysphagia may require NPO status or soft diet initially.
- No specific long-term dietary modifications are associated with Lemierre's syndrome.
5. Review of Systems
- HEENT: Sore throat, dysphagia, odynophagia, trismus, ear pain, neck pain/swelling
- Pulmonary: Cough, pleuritic chest pain, dyspnea, hemoptysis (septic pulmonary emboli are the most common metastatic complication) [1-2]
- MSK: Joint pain/swelling (septic arthritis) [3]
- GI/Abdominal: Abdominal pain (hepatic/splenic abscess) [3]
- Neurologic: Headache, focal deficits, altered mental status (brain abscess, meningitis) [3]
- GU: Dysuria, flank pain (renal abscess — rare) [3]
- Constitutional: Fevers, rigors, chills, night sweats, malaise, weight loss
6. Collateral History and Family History
- Collateral: Confirm timeline of pharyngitis onset, any prior ED visits or antibiotic prescriptions for sore throat, recent dental work, recent infectious mononucleosis
- EBV/Mononucleosis: ~10% of published cases are associated with concurrent infectious mononucleosis, which may facilitate mucosal invasion by F. necrophorum [14]
- Thrombophilia: Factor V Leiden and other inherited thrombophilias have been investigated but do not appear to be significantly overrepresented [5]
- Social history: IVDU (risk for MRSA-related Lemierre's), immunosuppression, recent incarceration or homelessness [10]
7. Risk Factors
- Age: Predominantly affects adolescents and young adults (median age ~20 years for classic Lemierre's) [4][11]
- Previously healthy — most patients have no significant comorbidities [11]
- Recent pharyngitis/tonsillitis — the primary risk factor [1-2]
- Concurrent EBV infection (~10% of cases) [14]
- Peritonsillar abscess or other deep neck space infections
- Reduced antibiotic prescribing for sore throat may be contributing to rising incidence [2][14]
- Diabetes mellitus — identified as a risk factor in atypical presentations [10]
- Immunosuppression (less commonly)
8. Differential Diagnosis
- Peritonsillar abscess (PTA): Unilateral throat pain, trismus, "hot potato" voice — but lacks IJV thrombosis and septic emboli
- Retropharyngeal/parapharyngeal abscess: Deep neck space infection with neck stiffness, dysphagia — can coexist with or progress to Lemierre's
- Ludwig's angina: Floor-of-mouth infection with airway compromise
- Infectious mononucleosis: Pharyngitis, lymphadenopathy, hepatosplenomegaly — can coexist with Lemierre's
- Septic pulmonary emboli from endocarditis: Right-sided endocarditis (especially IVDU) — obtain echocardiogram
- Community-acquired pneumonia with parapneumonic effusion: Bilateral cavitary lesions on CT should raise suspicion for septic emboli rather than simple CAP [8]
- Deep vein thrombosis of the IJV (non-septic): Central line-associated, malignancy-related
- Lymphoma/malignancy: Neck mass with constitutional symptoms in a young patient
- Cavernous sinus thrombosis: If facial/orbital symptoms predominate
9. Past Medical History
- Most patients are previously healthy — this is a hallmark of the disease [11]
- Ask about:
- Recurrent tonsillitis or prior tonsillectomy
- History of peritonsillar abscess
- Known thrombophilia or prior VTE
- Diabetes mellitus [10]
- Immunodeficiency (HIV, immunosuppressive medications)
- Recent EBV/mononucleosis [14]
- Prior episodes of Lemierre's (extremely rare recurrence)
10. Physical Exam
- Vitals: Fever (often high-grade), tachycardia, hypotension in septic shock; tachypnea if pulmonary involvement
- Oropharynx: Pharyngeal erythema, tonsillar exudates, peritonsillar fullness/abscess
- Neck: Unilateral tenderness, swelling, or induration along the SCM — the most important exam finding. May have palpable cord (thrombosed IJV). Cervical lymphadenopathy. [1][3]
- Lungs: Decreased breath sounds, crackles, pleural rub (septic emboli, empyema) [8]
- Joints: Effusion, warmth, erythema (septic arthritis)
- Abdomen: Hepatomegaly, RUQ tenderness (hepatic abscess)
- Skin: Petechiae, jaundice (in severe sepsis/DIC)
- Neuro: Focal deficits if brain abscess (rare) [3]
11. Lab Studies
- Blood cultures (at least 2 sets, aerobic AND anaerobic) — essential; F. necrophorum may take 48–72 hours to grow in anaerobic culture [1-2]
- CBC: Leukocytosis (often marked); thrombocytopenia is present in ~75% of Lemierre's patients on admission [11]
- CRP/ESR: Markedly elevated
- Procalcitonin: Elevated in bacterial sepsis
- BMP/CMP: Assess renal function, electrolytes; may show AKI
- LFTs: Elevated if hepatic involvement
- Coagulation studies (PT/INR, aPTT, fibrinogen, D-dimer): Assess for DIC
- Lactate: Elevated in sepsis/septic shock
- Throat culture (including anaerobic culture for F. necrophorum) [1]
- Targeted next-generation sequencing (tNGS): Emerging tool for rapid pathogen identification when conventional cultures are negative [7]
12. Imaging
- CT neck with IV contrast — gold standard for diagnosis; demonstrates IJV thrombosis, peritonsillar/parapharyngeal abscess, and surrounding soft tissue changes [1][3]
- CT chest with IV contrast — evaluate for septic pulmonary emboli (bilateral, peripheral, cavitary nodules), pleural effusion/empyema [1][8]
- Ultrasound of the neck — can be used as a rapid bedside screening tool to identify IJV thrombosis; useful in the ED but less sensitive than CT [1]
- Additional imaging as clinically indicated:
- CT abdomen/pelvis if abdominal symptoms (hepatic, splenic, renal abscess)
- MRI brain if neurologic symptoms (brain abscess) [3]
- Joint imaging if septic arthritis suspected
- When imaging is unnecessary: Standard pharyngitis without alarm features does not require imaging
13. Special Tests
- EBV serology (monospot, EBV VCA IgM/IgG): ~10% of cases have concurrent mononucleosis [14]
- Thrombophilia workup: Not routinely recommended acutely; may be considered in follow-up if recurrent VTE or strong family history, though prevalence of thrombophilia in Lemierre's does not appear elevated above background [5]
- Echocardiography: Consider to rule out endocarditis, especially if persistent bacteremia or IVDU
- Point-of-care ultrasound (POCUS): Bedside neck ultrasound for rapid IJV assessment; lung ultrasound for pleural effusion
- Lemierre Score/Criteria: No validated scoring system exists; diagnosis is clinical + imaging [4]
14. ECG
- Obtain ECG in all septic patients to assess for:
- Sinus tachycardia (most common)
- Arrhythmias secondary to sepsis
- Right heart strain pattern (S1Q3T3, right axis deviation, RBBB) if significant pulmonary septic emboli
- ST/T-wave changes suggesting myocarditis or septic cardiomyopathy
- No pathognomonic ECG findings for Lemierre's syndrome
15. Assessment
- Classic presentation: Young, previously healthy patient with recent pharyngitis → persistent/worsening fever → unilateral neck pain/swelling → respiratory symptoms from septic pulmonary emboli [1-2][4]
- Atypical presentations include: non-pharyngeal antecedent infections (otitis, dental, skin/soft tissue, trauma), non-Fusobacterium pathogens (MRSA, Streptococcus, Klebsiella), and non-IJV thrombosis [9-10]
- Severity stratification: 83% meet sepsis criteria; 18% develop septic shock; 43% require ICU admission [11]
- Mortality: ~2% 30-day mortality in modern series, though morbidity remains substantial with prolonged hospitalizations and long-term sequelae [4][11]
- Complications: Pulmonary abscess/empyema (most common), septic arthritis, hepatic abscess, renal abscess, brain abscess, DIC, ARDS [3][8]
16. Treatment Plan
Initial Stabilization
- Aggressive IV fluid resuscitation; vasopressors if refractory hypotension
- Early broad-spectrum IV antibiotics — do not delay for culture results
Antibiotic Regimen
- First-line: Piperacillin-tazobactam + metronidazole, OR carbapenem (meropenem) [2-3]
- Add vancomycin if MRSA risk factors [10]
- Narrow based on culture/sensitivity results
- Duration: 3–6 weeks total; IV initially, transition to oral when clinically improving [2]
Anticoagulation
- No consensus. The largest retrospective study (n=156) showed no significant mortality benefit. Thrombi often resolve with antibiotics alone. [12-13]
- Consider anticoagulation for: thrombus extension despite antibiotics, persistent bacteremia, extensive IJV thrombosis, or central venous involvement [10][13]
- If used: heparin initially → transition to warfarin or DOAC for 6–12 weeks [13]
Source Control
- Drainage of peritonsillar, parapharyngeal, or other drainable abscesses [6][9]
- Pleural drainage with fibrinolysis for complicated parapneumonic effusion/empyema [8]
- Surgical IJV ligation is rarely needed (reserved for refractory septic emboli despite adequate antibiotics) [1]
17. Disposition
- Admit all patients — Lemierre's syndrome requires inpatient management with IV antibiotics [1]
- ICU admission for: septic shock, respiratory failure, multiorgan dysfunction, need for vasopressors or mechanical ventilation (~43% require ICU) [11]
- Stepdown/floor for hemodynamically stable patients with controlled infection
- Specialist consultation:
- Infectious disease — for antibiotic optimization and duration
- ENT — for source control (abscess drainage, peritonsillar management)
- Hematology — if anticoagulation is being considered
- Interventional radiology — for percutaneous drainage of deep abscesses
- Pulmonology/thoracic surgery — for empyema management [8]
18. Follow Up / Return Precautions
- Follow-up: Infectious disease clinic within 1–2 weeks of discharge; repeat imaging (CT neck ± chest) at 4–6 weeks to confirm thrombus resolution and abscess clearance
- Antibiotic completion: Ensure full 3–6 week course is completed; oral step-down options include amoxicillin-clavulanate or metronidazole [2][9]
- If on anticoagulation: Hematology follow-up for duration management (typically 6–12 weeks) [13]
- Return precautions — instruct patients to return immediately for:
- Recurrent fevers or rigors
- Worsening neck pain or swelling
- New or worsening shortness of breath, chest pain, or hemoptysis
- New joint pain/swelling
- Headache with neurologic changes
- Signs of bleeding if on anticoagulation
- Expected recovery: Most patients recover fully with appropriate treatment, though prolonged hospitalization (mean ~21–29 days) is common. Restrictive lung defects may persist temporarily after pulmonary involvement. [8][12]
References
1. High Risk and Low Prevalence Diseases: Lemierre's Syndrome. — Carius BM, Koyfman A, Long B. The American Journal of Emergency Medicine. 2022.
2. Lemierre's Syndrome: A Forgotten and Re-Emerging Infection. — Lee WS, Jean SS, Chen FL, Hsieh SM, Hsueh PR. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 2020.
3. Lemierre's Syndrome Due to Fusobacterium Necrophorum. — Kuppalli K, Livorsi D, Talati NJ, Osborn M. The Lancet. Infectious Diseases. 2012.
4. Lemierre Syndrome: Current Evidence and Rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre Syndrome (BATTLE) Registry. — Valerio L, Corsi G, Sebastian T, Barco S. Thrombosis Research. 2020.
5. Invasive Fusobacterium Necrophorum Infections and Lemièrre's Syndrome: The Role of Thrombophilia and EBV. — Holm K, Svensson PJ, Rasmussen M. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 2015.
6. Lesson of the Month 1: Lemierre's Syndrome: A Reminder of the 'Forgotten Disease'. — Vijay V, Fattah Z. Clinical Medicine. 2018.
7. Early Diagnosis of Lemierre Syndrome Using Targeted Next-Generation Sequencing Combined With Metagenomics Capture: A Case Report and Literature Review. — Zhu Q, Liu Q. Medicine. 2026.
8. Lemierre Syndrome: Case Presentation of a Life-Threatening Septic Pneumonia With Complicated Parapneumonic Effusion: A Case Report. — Kim TH, Youn SH, Kim MA, et al. Medicine. 2024.
9. Lemierre Syndrome: A Case Report and Literature Review on Atypical Presentation. — Agonafir DB, Diress AE, Saleh AA, Dechasse CJ, Shane DK. Medicine. 2025.
10. Methicillin-Resistant Staphylococcus Aureus Septic Internal Jugular Thrombophlebitis: Updates in the Etiology and Treatment of Lemierre's Syndrome. — Correia MS, Sadler C. The Journal of Emergency Medicine. 2019.
11. Invasive Infections With Fusobacterium Necrophorum Including Lemierre's Syndrome: An 8-Year Swedish Nationwide Retrospective Study. — Nygren D, Holm K. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.
12. Anticoagulation Treatment in Patients With Septic Thrombophlebitis of the Internal Jugular Vein. — Senda A, Fushimi K, Morishita K. The Western Journal of Emergency Medicine. 2025.
13. Anticoagulation Strategies in the Management of Lemierre Syndrome: A Systematic Review of the Literature. — Adedeji A, Chukwura O, Obafemi T, McNulty SB, Reinert JP. The Annals of Pharmacotherapy. 2021.
14. Human Infection With Fusobacterium Necrophorum (Necrobacillosis), With a Focus on Lemierre's Syndrome. — Riordan T. Clinical Microbiology Reviews. 2007.